9/10/2026
FDA outlines new psychedelic drug framework in NEJM
The FDA highlights its evolving approach to psychedelic therapies amid a mental health crisis.
Topic archive
2 stories
9/10/2026
The FDA highlights its evolving approach to psychedelic therapies amid a mental health crisis.
7/22/2026
Trump's 2026 executive order boosts psychedelic research funding and collaboration.